Scientist for Medical Affairs at P&G Health, Germany
Dr. Christian Viel is a distinguished pharmacist and scientist specializing in pharmacology and clinical pharmacy. Currently, he serves as a Scientist for Medical Technical Affairs at P&G Health Germany GmbH. With expertise in cholinergic and mitochondrial dysfunction, his research primarily focuses on neurodegenerative diseases, including Alzheimer’s. Dr. Viel has an extensive academic background, having earned his Dr. phil. nat. (equivalent to Ph.D.) in pharmacology with magna cum laude honors from Goethe University Frankfurt. His contributions to scientific literature include several publications in renowned journals, emphasizing mitochondrial function, oxidative stress, and pharmacological interventions.
Profile
ORCID
🎓 Education
Dr. Viel’s educational journey reflects his strong foundation in pharmacology and pharmaceutical sciences. He obtained his Ph.D. in pharmacology from Goethe University Frankfurt in 2022, graduating with magna cum laude honors. His doctoral research was conducted at the Institute for Pharmacology & Clinical Pharmacy, where he investigated cholinergic and mitochondrial dysfunctions linked to Alzheimer’s disease. Prior to his Ph.D., he earned his pharmacy license in 2017, also from Goethe University. He completed his undergraduate studies in pharmacy between 2010 and 2015, establishing a comprehensive academic grounding in pharmacology, medicinal chemistry, and pharmaceutical practices.
💼 Experience
Dr. Viel’s professional experience spans both industry and academia. Since 2022, he has been working at P&G Health Germany GmbH as a Scientist for Medical Technical Affairs. His role involves contributing to the development of medical and technical solutions, with a focus on pharmaceutical products. From 2017 to 2022, he was a research associate at Goethe University Frankfurt, where he conducted groundbreaking research on mitochondrial dysfunction and Alzheimer’s disease. During this period, he also gained hands-on experience as a part-time pharmacist at Apotheke an der Hauptwache in Frankfurt (since 2018) and at 5K Apotheke Frankfurt in 2017. Additionally, he completed an internship at Merck Consumer Health from 2016 to 2017, working at the global medical center.
🔬 Research Interests
Dr. Viel’s research interests lie at the intersection of pharmacology and neuroscience. His primary focus is on mitochondrial and cholinergic dysfunction in neurodegenerative diseases, particularly Alzheimer’s. He is also interested in studying the impact of oxidative stress on brain function and exploring the potential of antioxidants and other pharmacological interventions. His expertise extends to experimental models of ischemia, epilepsy, and mitochondrial disorders, contributing to the development of therapeutic strategies aimed at improving brain health and combating neurodegeneration.
🏅 Awards
While the document does not explicitly mention awards, Dr. Viel’s magna cum laude distinction for his Ph.D. reflects his academic excellence. His invitations to present at prestigious conferences, including the Doktorandentagung DPhG (2022), Pharmazeutisches Kolloquium at Goethe University (2021), and NeuroDiab (2023), demonstrate the recognition of his expertise within the scientific community. His involvement as a speaker at “Brückenschlagen – Wissenschaft in die Schule,” a project of Goethe University, highlights his contributions to science communication and education.
📝 Publications
Dr. Viel has authored multiple scientific publications in high-impact journals, focusing on neuropharmacology and mitochondrial function. Below are seven of his key publications:
Effects of Magnesium Orotate, Benfotiamine, and a Combination of Vitamins on Mitochondrial and Cholinergic Function in the TgF344-AD Rat Model of Alzheimer’s Disease
Journal: Pharmaceuticals (2021)
Cited by: Articles referencing Alzheimer’s disease models and neuroprotection strategies.
Book chapter: Microdialysis to measure cholinergic activity in rodent brain
Publisher: Neuromethods, Springer Nature (pending publication)
Cited by: N/A (pending publication).
ß-Hydroxybutyrate improves mitochondrial function after transient ischemia in the mouse
Journal: Neurochemical Research (2022)
Cited by: Studies on mitochondrial function and ischemic brain injuries.
Oxidative stress in rat brain during experimental status epilepticus: effect of antioxidants
Journal: Frontiers in Pharmacology (2023)
Cited by: Research on oxidative stress and neuroprotection.
✅ Conclusion
Dr. Christian Viel’s pioneering research on mitochondrial function, Alzheimer’s disease, and pharmacological interventions highlights his significant contributions to medical science. His ability to blend fundamental research with practical pharmaceutical applications at P&G Health demonstrates exceptional innovation.
With a strong publication record, impactful research, and dedication to knowledge dissemination, Dr. Viel is undoubtedly a deserving candidate for the Best Innovation Award.